Ambev
$2.90Change from previous close: −0.68%Absolute change: −$0.02
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $44.71B
- Enterprise value
- $30B
- P/E (trailing 12 months)
- 14.5
- Forward P/E
- 13.6
- PEG
- 1.90
- Price/book
- 2.64
- Price/sales
- 0.51
- EV/EBITDA
- 1.12
- EV/revenue
- 0.34
Profitability and growth
- Gross margin
- 51.9%
- Operating margin
- 23.7%
- Net margin
- 18.4%
- ROE
- 18.4%
- ROA
- 10.3%
- Revenue growth (year over year)
- 0.3%
- Earnings growth (year over year)
- 24.6%
Financial health
- Total cash
- $18.35B
- Total debt
- $2.95B
- Debt/equity
- 0.03
- Current ratio
- 1.02
- Quick ratio
- 0.67
Dividends
- Annual dividend per share
- $0.16
- Dividend yield
- 5.5%
- Payout ratio
- 77.0%
- Ex-dividend date
- September 23, 2026
Analysts and estimates
- Average price target
- $3.35
- Median price target
- $3.44
- High price target
- $4.00
- Low price target
- $2.64
- Analysts with a price target
- 10
- Consensus
- Hold
- Forward EPS
- $0.21
- EPS estimate, current year
- $0.20
Shares and trading
- Beta
- 0.25
- Average volume
- 27.02M
- Shares outstanding
- 15.42B
- Float
- 4.05B
- Institutional ownership
- 7.2%
- Insider ownership
- 0.0%
- Short ratio (days)
- 4.53